Mitochondrial DNA rearrangements in young onset parkinsonism: Two case reports

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 5, 2001, Pages 685-687

  Siciliano, G ^a   Mancuso, M ^a   Ceravolo, R ^a   Lombardi, V ^a   Iudice, A ^a   Bonuccelli, U ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Mitochondrial encephalomyopathies; mtDNA deletions; Parkinson's disease

Indexed keywords

BENSERAZIDE; CARBIDOPA; LEVODOPA; MITOCHONDRIAL DNA; ROPINIROLE; TOLCAPONE;

ADULT; ARTICLE; BRAIN BIOPSY; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FAMILY HISTORY; HISTOPATHOLOGY; HUMAN; MALE; PARKINSONISM; PATHOGENESIS; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL;

ADULT; CREATINE KINASE; DNA, MITOCHONDRIAL; GENE REARRANGEMENT; HUMANS; LACTIC ACID; LIPOMATOSIS, MULTIPLE SYMMETRICAL; MALE; MIDDLE AGED; PARKINSON DISEASE; PEDIGREE;

EID: 0034776305     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.5.685     Document Type: Article

References (16)

1. Di Mauro S, Schon EA. Mitochondrial DNA and diseases of the nervous system. The spectrum. Neuroscientist 1997; 4:53-63.
2. Vyas I, Heikkila RE, Nicklas WJ. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-pyridinium. J Neurochem 1986;46:1501-7.
3. Schapira AHV, Cooper JM, Dexter D, et al. Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1989;i: 1269.
4. Mizumo Y, Ikebe S, Hattori N, et al. Role of mitochondria in etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1995;1271:265-74.
5. Truong DD, Harding AE, Scaravilli F, et al. Movement disorders in mitochondrial myopathies. A study of nine cases with two autopsy studies. Mov Disord 1990;5:109-17.
6. Chalmers RAI, Brockington M, Howard RS, et al. Mitochondrial encephalopathy with multiple mitochondrial DNA deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features. J Neurol Sci 1996;143:41-5.
7. Kosel S, Grasbon-Frodl EM, Mautsch U, et al. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease. Neurogenetics 1998;1:197-204.
8. Grasbon-Frodl EM, Kosel S, Sprinzl M, et al. Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease. Neurogenetics 1999;2: 121-7.
9. Siciliano G, Renna M, Manca ML, et al. The relationship of plasma catecholamine and lactate during anaerobic threshold exercise in mitochondrial myopathies. Neuromuscul Disord 1999;9:411-16.
10. Klopstock T, Naumann M, Seibel P, et al. Mitochondrial DNA mutations in multiple symmetric lipomatosis. Mol Cell Biochem 1997;174:271-5.
11. Zeviani M, Servidei S, Gellera C, et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting at the D-loop region. Nature 1989;339:309-11.
12. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-7.
13. Lucking CB, Abbas N, Durr A, et al. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. Lancet 1998;352:1355-6.
14. Schnopp NM, Kosel S, Egensperger R, et al. Regional heterogeneity of mtDNA heteroplasmy in parkinsonian brain. Clin Neuropathol 1996;15:348-52.
15. Swerdlow RH, Parks JK, Miller SW, et al. Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 1996;40:663-71.
16. Kosel S, Egensperger R, Schnopp NM, et al. The common deletion is not increased in parkinsonian substantia nigra as shown by competitive polymerase chain reaction Mov Disord 1997;12:639-15.